For instance, in the db/db mouse model, the levels of inflammatory factors such as IL-1, IL-6, CCL2, and CXCL1 in the muscle tissue of mice all decreased significantly after treatment with GLP-1RA dulaglutide
summarized and analyzed all research on the prevalence of CMD in HFpEF patients, finding a high pooled prevalence of 71% [29]
March 8, 2026: More Deaths, Adverse Events Reported About Patients Taking Mounjaro, Other GLP-1s The U.K.s Medicines and Healthcare products Regulatory Authority received 1,296 reports of pancreatitis involving patients taking GLP-1 drugs (like Mounjaro) between 2007 and 2025
2020;26(suppl 16):S335-S343.
Can IV therapy really shorten my recovery time after surgery or illness